Xconomy

From Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study:

carolgallagher
carolgallagher

Carol Gallagher is CEO of Calistoga Pharmaceuticals.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.